# NeuroNova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuronova

- Industry: Biotechnology
- Headquarters: Munich, Germany
- Website: www.neuronova.de
- Total disclosed funding: $30M
- Latest round: Series D (Mar 22, 2010)
- Investors on record: 6

## About

NeuroNova AG is a biopharmaceutical company focusing on the development and commercialisation of novel drugs against depression, bipolar affective disorders, and anxiety.

## Funding rounds

- Series D, Mar 22, 2010, $4.5M — EMBL Ventures, EQT Life Sciences, KfW Banking Group, Aescap Venture, Bayern Kapital
- Series C, Oct 24, 2006, $15M — EMBL Ventures, EQT Life Sciences, KfW Banking Group, Aescap Venture, Bayern Kapital, Sunrise Water Ltd.
- Series B, Apr 13, 2005, $5.2M — EMBL Ventures, EQT Life Sciences, KfW Banking Group, Bayern Kapital, Sunrise Water Ltd.
- Series A, Nov 10, 2003, $4.7M — EQT Life Sciences

## Investors

- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A, Series B, Series C, Series D
- EMBL Ventures (https://capitalatlas.ai/funds/embl-ventures) — Series B, Series C, Series D
- KfW Banking Group — Series B, Series C, Series D
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Series B, Series C, Series D
- Sunrise Water Ltd. — Series B, Series C
- Aescap Venture (https://capitalatlas.ai/funds/aescap-venture) — Series C, Series D